Financial News
Alnylam Pharmaceuticals (NQ: ALNY )
234.84
-3.04
(-1.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Headline News about Alnylam Pharmaceuticals
![](https://www.investors.com/wp-content/uploads/2018/04/stock-drugs-12-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Analyst Ratings for Alnylam Pharmaceuticals
June 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Via Talk Markets
![](/next-assets/images/schema-image-default.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Alnylam Pharmaceuticals Stands With Analysts
May 05, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/07/covid-19_vaccination-photo_by_johaehn_from_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2023/06/A1-060523-Bigpharma-chrisgash.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/22/alny.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_7754.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/27/dementia-3051832_1920.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/pill-bottle-biopharma-biotech-1600.jpg)
![](/next-assets/images/schema-image-default.png)
A Bearish Sign Appears On Alnylam Pharmaceuticals's Chart
April 11, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Alnylam Pharmaceuticals
March 21, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Alnylam Pharmaceuticals's Return On Capital Employed Insights
February 27, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
10 Health Care Stocks With Whale Alerts In Today's Session
April 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/12/arwr.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/abus_1_0.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/04/medical-device-stocks-hospital-stocks-healthcare-stocks.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.